Combined CDK4/6 and PD-1 Inhibition in Refractory SMARCA4-Deficient Small-Cell Carcinoma of the Ovary, Hypercalcemic Type

JCO Precis Oncol. 2020;4:736-742. doi: 10.1200/PO.20.00063. Epub 2020 Jun 24.
No abstract available